Su, C., Huang, T., Shih, C., & Su, Y. (2025). Risk Factors and Multiple Interaction Effects for Hyperammonemia in Patients Receiving Valproic Acid. Fundamental & clinical pharmacology, 39(4), e70030-n/a. https://doi.org/10.1111/fcp.70030
Chicago Style (17th ed.) CitationSu, Chien‐Chou, Tsai‐Kuei Huang, Ching‐Sen Shih, and Yi‐Chia Su. "Risk Factors and Multiple Interaction Effects for Hyperammonemia in Patients Receiving Valproic Acid." Fundamental & Clinical Pharmacology 39, no. 4 (2025): e70030-n/a. https://doi.org/10.1111/fcp.70030.
MLA (9th ed.) CitationSu, Chien‐Chou, et al. "Risk Factors and Multiple Interaction Effects for Hyperammonemia in Patients Receiving Valproic Acid." Fundamental & Clinical Pharmacology, vol. 39, no. 4, 2025, pp. e70030-n/a, https://doi.org/10.1111/fcp.70030.